1.
Human papillomavirus and cervical cancer
by Crosbie, Emma J, PhD
The Lancet (British edition), 2013, Vol.382 (9895), p.889-899
3.
A novel group of rhinoviruses is associated with asthma hospitalizations
by Miller, E. Kathryn, MD, MPH
Journal of allergy and clinical immunology, 2009, Vol.123 (1), p.98-104.e1
4.
A genome-wide association study identifies novel risk loci for type 2 diabetes
by Meyre, David
Nature, 2007-02-22, Vol.445 (7130), p.881-885
5.
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
by Villa, Luisa L
Vaccine, 2006, Vol.24 (27), p.5571-5583
6.
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neopl...
by Trimble, Cornelia L, Prof
The Lancet (British edition), 2015, Vol.386 (10008), p.2078-2088
7.
Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis
by Lafaille, Fabien G
Nature Medicine, 2019-12, Vol.25 (12), p.1873-1884
8.
Understanding individual human mobility patterns
by Barabási, Albert-László
Nature, 2008-06-05, Vol.453 (7196), p.779-782
9.
Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases
by Saraya, Takeshi
Respiratory medicine, 2018-03, Vol.136, p.88-92
10.
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
by Ndiaye, Cathy, PhD
The lancet oncology, 2014, Vol.15 (12), p.1319-1331
11.
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology: Results From the ATHENA HPV Study
by STOLER, Mark H
American journal of clinical pathology, 2011, Vol.135 (3), p.468-475
12.
A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men
by Van Damme, Pierre
Vaccine, 2016-07-29, Vol.34 (35), p.4205-4212
13.
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
by Kunisaki, Ken M, MD
The Lancet infectious diseases, 2009, Vol.9 (8), p.493-504
14.
Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013–17: an epidemiological study of laboratory-confirmed case series
by Wang, Xiling, PhD
The Lancet infectious diseases, 2017, Vol.17 (8), p.822-832
15.
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
by Dawood, Fatimah S, Dr
The Lancet infectious diseases, 2012, Vol.12 (9), p.687-695
16.
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of t...
by Wheeler, Cosette M, Dr, Prof
The lancet oncology, 2012, Vol.13 (1), p.100-110
17.
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France
by Loubet, P
Clinical microbiology and infection, 2017-04, Vol.23 (4), p.253-259
18.
The Challenge to Be Inclusive and Diversify Our Aging Populations
by Alegría, Margarita
The American journal of geriatric psychiatry, 2022-04, Vol.30 (4), p.475-477
19.
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome
by Paik, Young-Ki
Nature biotechnology, 2012-03-07, Vol.30 (3), p.221-223
20.
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
by Kreimer, Aimée R, Dr
The lancet oncology, 2015, Vol.16 (7), p.775-786
